Head to Head Analysis: Basel Medical Group (NASDAQ:BMGL) and Establishment Labs (NASDAQ:ESTA)

Establishment Labs (NASDAQ:ESTA) and Basel Medical Group (NASDAQ:BMGL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation and analyst recommendations.

Earnings & Valuation

This table compares Establishment Labs and Basel Medical Group”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$190.97 million	10.03	-$84.60 million	($2.84)	-23.21
Basel Medical Group	$8.90 million	1.69	-$9.50 million	N/A	N/A

Basel Medical Group has lower revenue, but higher earnings than Establishment Labs.

Analyst Recommendations

This is a summary of recent recommendations for Establishment Labs and Basel Medical Group, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1	1	6	0	2.63
Basel Medical Group	1	0	0	0	1.00

Establishment Labs presently has a consensus price target of $78.86, indicating a potential upside of 19.63%. Given Establishment Labs’ stronger consensus rating and higher probable upside, equities research analysts plainly believe Establishment Labs is more favorable than Basel Medical Group.

Profitability

This table compares Establishment Labs and Basel Medical Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-43.45%	-235.45%	-22.83%
Basel Medical Group	N/A	N/A	N/A

Institutional & Insider Ownership

72.9% of Establishment Labs shares are held by institutional investors. 11.1% of Establishment Labs shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Establishment Labs beats Basel Medical Group on 7 of the 11 factors compared between the two stocks.

About Establishment Labs

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.